Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Nenadic

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
JAMA Psychiatry|August 24, 2022
Functional Connectivity of the Nucleus Accumbens and Changes in Appetite in Patients With DepressionNils B Kroemer, Nils Opel, Vanessa Teckentrup, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 22, 2011
Reduced cortical thickness is associated with the glutamatergic regulatory gene risk variant DAOA Arg30Lys in schizophreniaC Christoph Schultz, Igor Nenadic, Kathrin Koch, et al.
Neuroimage|July 1, 2008
Frontal-striatal-thalamic mediodorsal nucleus dysfunction in schizophrenia-spectrum patients during sensorimotor gatingErin A Hazlett, Monte S Buchsbaum, Jing Zhang, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 15, 2010
Phospholipase A₂ activity in first episode schizophrenia: associations with symptom severity and outcome at week 12Stefan Smesny, Christina Kunstmann, Sebastian Kunstmann, et al.
Journal of Psychiatric Research|September 29, 2012
Glutamate receptor δ 1 (GRID1) genetic variation and brain structure in schizophreniaIgor Nenadic, Raka Maitra, Sigrid Scherpiet, et al.
Schizophrenia Research|February 4, 2011
Resequencing and follow-up of neurexin 1 (NRXN1) in schizophrenia patientsThomas W Mühleisen, F Buket Basmanav, Andreas J Forstner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 28, 2021
Correction to: Biological sex classification with structural MRI data shows increased misclassification in transgender womenClaas Flint, Katharina Förster, Sophie A Koser, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 10, 2020
Biological sex classification with structural MRI data shows increased misclassification in transgender womenClaas Flint, Katharina Förster, Sophie A Koser, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 7, 2021
Systematic misestimation of machine learning performance in neuroimaging studies of depressionClaas Flint, Micah Cearns, Nils Opel, et al.
Schizophrenia Research|September 29, 2012
Genetic variation at the synaptic vesicle gene SV2A is associated with schizophreniaManuel Mattheisen, Thomas W Mühleisen, Jana Strohmaier, et al.
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
JAMA Psychiatry|August 24, 2022
Functional Connectivity of the Nucleus Accumbens and Changes in Appetite in Patients With DepressionNils B Kroemer, Nils Opel, Vanessa Teckentrup, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 22, 2011
Reduced cortical thickness is associated with the glutamatergic regulatory gene risk variant DAOA Arg30Lys in schizophreniaC Christoph Schultz, Igor Nenadic, Kathrin Koch, et al.
Neuroimage|July 1, 2008
Frontal-striatal-thalamic mediodorsal nucleus dysfunction in schizophrenia-spectrum patients during sensorimotor gatingErin A Hazlett, Monte S Buchsbaum, Jing Zhang, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 15, 2010
Phospholipase A₂ activity in first episode schizophrenia: associations with symptom severity and outcome at week 12Stefan Smesny, Christina Kunstmann, Sebastian Kunstmann, et al.
Journal of Psychiatric Research|September 29, 2012
Glutamate receptor δ 1 (GRID1) genetic variation and brain structure in schizophreniaIgor Nenadic, Raka Maitra, Sigrid Scherpiet, et al.
Schizophrenia Research|February 4, 2011
Resequencing and follow-up of neurexin 1 (NRXN1) in schizophrenia patientsThomas W Mühleisen, F Buket Basmanav, Andreas J Forstner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 28, 2021
Correction to: Biological sex classification with structural MRI data shows increased misclassification in transgender womenClaas Flint, Katharina Förster, Sophie A Koser, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 10, 2020
Biological sex classification with structural MRI data shows increased misclassification in transgender womenClaas Flint, Katharina Förster, Sophie A Koser, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 7, 2021
Systematic misestimation of machine learning performance in neuroimaging studies of depressionClaas Flint, Micah Cearns, Nils Opel, et al.
Schizophrenia Research|September 29, 2012
Genetic variation at the synaptic vesicle gene SV2A is associated with schizophreniaManuel Mattheisen, Thomas W Mühleisen, Jana Strohmaier, et al.
Pageof 12